Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation

被引：25
作者：
Laryea, Marie A. [2 ]
Watt, Kymberly D. [1 ]
机构：
[1] Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] Dalhousie Univ, Multiorgan Transplant Program, Halifax, NS, Canada
来源：
LIVER TRANSPLANTATION | 2012年 / 18卷 / 05期
关键词：
B IMMUNE GLOBULIN; HBV-RELATED CIRRHOSIS; TERM-FOLLOW-UP; VIRUS RECURRENCE; ADEFOVIR DIPIVOXIL; SURFACE-ANTIGEN; POSITIVE GRAFTS; LOW-RISK; LAMIVUDINE; PROPHYLAXIS;
D O I：
10.1002/lt.23408
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The reinfection of the hepatic allograft with hepatitis B virus and hepatitis C virus can have important sequelae that result in poor long-term patient and graft survival. Although a response to treatment with antiviral medications can improve these outcomes, not all patients tolerate these medications or experience viral eradication. Avoiding reinfection of the graft is the most effective means of improving the long-term outcomes for these patient populations. This review is focused on the prevention of viral hepatitis reinfection after liver transplantation. Liver Transpl, 2012. (C) 2012 AASLD.
引用
收藏
页码：514 / 523
页数：10
相关论文
共 62 条
[31]   Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation [J].
Katz, Lior H. ;
Tur-Kaspa, Ran ;
Guy, Daniel G. ;
Paul, Mical .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (07)
[32]   LONG-TERM FOLLOW-UP OF HEPATITIS-B VIRUS-INFECTED RECIPIENTS AFTER ORTHOTOPIC LIVER-TRANSPLANTATION [J].
KONIG, V ;
HOPF, U ;
NEUHAUS, P ;
BAUDITZ, J ;
SCHMIDT, CA ;
BLUMHARDT, G ;
BECHSTEIN, WO ;
NEUHAUS, R ;
LOBECK, H .
TRANSPLANTATION, 1994, 58 (05) :553-559
[33]   Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence [J].
Lenci, Ilaria ;
Tisone, Giuseppe ;
Di Paolo, Daniele ;
Marcuccilli, Fabio ;
Tariciotti, Laura ;
Ciotti, Marco ;
Svicher, Valentina ;
Perno, Carlo Federico ;
Angelico, Mario .
JOURNAL OF HEPATOLOGY, 2011, 55 (03) :587-593
[34]   Liver transplantation from hepatitis B surface antigen positive donors: A safe way to expand the donor pool [J].
Loggi, Elisabetta ;
Micco, Lorenzo ;
Ercolani, Giorgio ;
Cucchetti, Alessandro ;
Bihl, Florian K. ;
Grazi, Gian Luca ;
Gitto, Stefano ;
Bontadini, Andrea ;
Bernardi, Mauro ;
Grossi, Paolo ;
Costa, Alessandro Nanni ;
Pinna, Antonio Daniele ;
Brander, Christian ;
Andreone, Pietro .
JOURNAL OF HEPATOLOGY, 2012, 56 (03) :579-585
[35]   Chronic Hepatitis B: Update 2009 [J].
Lok, Anna S. F. ;
McMahon, Brian J. .
HEPATOLOGY, 2009, 50 (03) :661-662
[36]   Hepatitis B immunoglobulin and lamivudine improve hepatitis B-related outcomes after liver transplantation: Meta-analysis [J].
Loomba, Rohit ;
Rowley, Ayana K. ;
Wesley, Robert ;
Smith, Karen G. ;
Liang, T. Jake ;
Pucino, Frank ;
Csako, Gyorgy .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (06) :696-700
[37]   Hepatitis B prophylaxis post-liver transplant without maintenance hepatitis B immunoglobulin therapy [J].
Nath, DS ;
Kalis, A ;
Nelson, S ;
Payne, WD ;
Lake, JR ;
Humar, A .
CLINICAL TRANSPLANTATION, 2006, 20 (02) :206-210
[38]   EASL Clinical Practice Guidelines [J].
Pawlotsky, Jean-Michel .
JOURNAL OF HEPATOLOGY, 2009, 50 (02) :243-246
[39]   HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis [J].
Roche, B ;
Feray, C ;
Gigou, M ;
Roque-Afonso, AM ;
Arulnaden, JL ;
Delvart, V ;
Dussaix, E ;
Guettier, C ;
Bismuth, H ;
Samuel, D .
HEPATOLOGY, 2003, 38 (01) :86-95
[40]   Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation -: possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection [J].
Rosenau, J ;
Bahr, MJ ;
Tillmann, HL ;
Trautwein, C ;
Klempnauer, J ;
Manns, MP ;
Böker, KHW .
JOURNAL OF HEPATOLOGY, 2001, 34 (06) :895-902
1234567